Hims & Hers Health (HIMS) EBIAT (2019 - 2026)

Hims & Hers Health has disclosed EBIAT across 8 years of filings, most recently posting -$92.1 million for Q1 2026.

• EBIAT for Q1 2026 came in at -$92.1 million, down 286.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$13.2 million (down 108.05% YoY), and the FY2025 annual result was $128.4 million, up 1.85% from the prior year.
• EBIAT came in at -$92.1 million for Q1 2026 at Hims & Hers Health, down from $20.6 million in the prior quarter.
• In the past five years, EBIAT ranged from a high of $75.6 million in Q3 2024 to a low of -$92.1 million in Q1 2026.
• The 5-year median for EBIAT is $1.2 million (2023), against an average of $4.3 million.
• Across the five-year window, EBIAT soared 1990.36% in 2024 and plunged 286.15% in 2026, its largest moves.
• Hims & Hers Health's EBIAT stood at -$10.9 million in 2022, then soared by 111.41% to $1.2 million in 2023, then jumped by 1990.36% to $26.0 million in 2024, then declined by 20.84% to $20.6 million in 2025, then sank by 547.14% to -$92.1 million in 2026.
• The last three EBIAT figures came in at -$92.1 million (Q1 2026), $20.6 million (Q4 2025), and $15.8 million (Q3 2025), per Business Quant data.